Theresa Rosario-Jansen

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · New England Journal of Medicine · 2007 · 3K citations · Full text

Medicine, Pharmacotherapy, Bone Augmentation +16

Design and conduct of clinical trials in patients with osteoarthritis: Recommendations from a task force of the Osteoarthritis Research Society

Roy D. Altman, Kenneth D. Brandt, Marc C. Hochberg et al. · Osteoarthritis and Cartilage · 1996 · 574 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +16

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 1. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Discovery and Variation of the 5-Keto Substituent

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 53 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

New Cyclooxygenase-2/5-Lipoxygenase Inhibitors. 3. 7-<i>tert</i>-Butyl-2,3-dihydro-3,3-dimethylbenzofuran Derivatives as Gastrointestinal Safe Antiinflammatory and Analgesic Agents:  Variations at the 5 Position

John M. Janusz, Patricia A. Young, James M. Ridgeway et al. · Journal of Medicinal Chemistry · 1998 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

Dennis M. Black, Pierre D. Delmas, Richard Eastell et al. · Obstetrical & Gynecological Survey · 2007 · 43 citations

Medicine, Pharmacotherapy, Bone Augmentation +16